VA Office of Research and Development
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, VA Office of Research and Development sits in the top decile of US sponsors by registered trial count (#11 of 15,751 sponsors by registered trial count).
VA Office of Research and Development: 1,668 sponsored US clinical trials, 291 recruiting.
VA Office of Research and Development sponsors 1,668 registered US clinical trials on ClinicalTrials.gov, 291 of them currently recruiting, and 1,108 completed. 124 of these trials are in Phase 3-4 (later-stage) and 236 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is PTSD, with 28 trials.
Top-decile sponsor footprint
VA Office of Research and Development ranks in the top decile of sponsors by registered trial count (#11 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,668 total, page 34 of 34
Antiarrhythmic Effects of Spironolactone in Patients With ICDs
NCT04495712
Cognitive Rehabilitation in Schizophrenia
NCT00248794
Comparison of Acid Reflux at Two Levels in the Esophagus Using the BRAVO Capsule
NCT00579410
Shoe Modification and Knee Osteoarthritis
NCT00105365
Genetic Research in Schizophrenia Using DNA Markers and Clinical Phenotypes
NCT00108303
Divalproex Sodium in the Treatment of PTSD (Post-Traumatic Stress Disorder)
NCT00108576
Testosterone Replacement Therapy in Chronic Spinal Cord Injury
NCT00266864
Humoral Determinants of Immunity to Pneumococcal Infection
NCT00304382
Standard Open Surgery Versus Endovascular Repair of Abdominal Aortic Aneurysm (AAA)
NCT00094575
Relatively Healthy Male Veterans Observed Over Time to See What Types of Diseases Develop
NCT00076141
Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT)
NCT00032487
Work Activity Augmented by Cognitive Rehabilitation for Schizophrenia
NCT00430560
Defective Atypical Protein Kinase C (PKC) Activation in Diabetes and Metabolic Syndrome
NCT00690755
Post-Traumatic Stress Disorder (PTSD) Symptom Study
NCT00018798
Integrated Intervention for Substance Abusers With Depressive Disorders
NCT00018655
Neural Networks and Language Recovery in Aphasia From Stroke: fMRI Studies
NCT00467103
Prostate Cancer Intervention Versus Observation Trial (PIVOT)
NCT00007644
The VA HDL Intervention Trial (HIT): Secondary Prevention of Coronary Heart Disease in Men With Low HDL-Cholesterol and Desirable LDL-Cholesterol
NCT00283335
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 89 |
| Phase 2 | 147 |
| Phase 3 | 55 |
| Phase 4 | 69 |
Therapeutic Areas
What is open in the VA Office of Research and Development pipeline
291 recruiting of 1,668 indexed (17% open); 1,108 completed (66%).
Phase mix: 124 late (III/IV) vs 236 early (I/II) (early-phase heavy).
Top condition: PTSD (28 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.